Stay updated on Pembrolizumab in EOC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in EOC Clinical Trial page.

Latest updates to the Pembrolizumab in EOC Clinical Trial page
- Check4 days agoChange DetectedThe study page now indicates the trial is no longer recruiting. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was updated with a new page revision noted as v3.6.0.SummaryDifference0.5%

- Check11 days agoChange DetectedThe page's revision tag was updated to v3.5.5, indicating a small internal update to the page's documentation or rendering.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedAdded a new page revision label 'Revision: v3.5.4' and removed the previous 'Revision: v3.5.3', indicating an update to the page metadata. The update appears to reflect record maintenance rather than changes to the study details.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page’s software/version label was updated from Revision v3.5.2 to v3.5.3, indicating a minor site release without altering the clinical trial study details.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the page.SummaryDifference0.1%

- Check90 days agoChange DetectedPage revision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in EOC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in EOC Clinical Trial page.